FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319301683> ?p ?o ?g. }

• W4319301683 endingPage "100783" @default.
• W4319301683 startingPage "100783" @default.
• W4319301683 abstract "There is no clear consensus on the optimal systemic treatment regimen in combined hepatocellular-cholangiocarcinoma (cHCC-CCA) patients. We describe clinical characteristics and outcome of cHCC-CCA patients, with a special focus on patients receiving palliative systemic therapy, including immune checkpoint inhibitors (ICIs).In this European retrospective, multicenter study, patients with histologically proven cHCC-CCA treated at four institutions between April 2003 and June 2022 were included. In patients receiving palliative systemic therapy, outcome was compared between cytotoxic chemotherapy (CHT)- and non-cytotoxic CHT (nCHT)-treated patients.Of 101 patients, the majority were male (n = 70, 69%) with a mean age of 64.6 ± 10.6 years. Only type of first-line treatment was independently associated with overall survival (OS). Palliative systemic therapy was administered to 44 (44%) patients. Of those, 25 (57%) patients received CHT and 19 (43%) had nCHT (n = 16 of them sorafenib) in systemic first line. Although there was no significant difference in overall response rate (ORR; CHT versus nCHT: 8% versus 5%), disease control rate (24% versus 21%), and median progression-free survival {3.0 months [95% confidence interval (CI) 1.4-4.6 months] versus 3.2 months (95% CI 2.8-3.6 months), P = 0.725}, there was a trend towards longer median OS in the CHT group [15.5 months (95% CI 8.0-23.0 months) versus 5.3 months (95% CI 0-12.5 months), P = 0.052]. However, in multivariable analysis, type of first-line regimen (CHT versus sorafenib) was not associated with OS. ORR in patients receiving ICIs (n = 7) was 29%.In patients with cHCC-CCA, OS, progression-free survival, ORR, and disease control rate were not significantly different between individuals receiving CHT and patients receiving nCHT. Immunotherapy may be effective in a subset of patients. Prospective studies are needed to identify optimal systemic treatment regimens in cHCC-CCA." @default.
• W4319301683 created "2023-02-07" @default.
• W4319301683 creator A5004228804 @default.
• W4319301683 creator A5005036299 @default.
• W4319301683 creator A5018623031 @default.
• W4319301683 creator A5024115698 @default.
• W4319301683 creator A5024485263 @default.
• W4319301683 creator A5035002011 @default.
• W4319301683 creator A5048534007 @default.
• W4319301683 creator A5052362769 @default.
• W4319301683 creator A5055058026 @default.
• W4319301683 creator A5079645039 @default.
• W4319301683 creator A5084197662 @default.
• W4319301683 creator A5087125537 @default.
• W4319301683 creator A5090751499 @default.
• W4319301683 date "2023-02-01" @default.
• W4319301683 modified "2023-09-27" @default.
• W4319301683 title "Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma—a European multicenter cohort" @default.
• W4319301683 cites W2079586464 @default.
• W4319301683 cites W2771017141 @default.
• W4319301683 cites W2789901176 @default.
• W4319301683 cites W2806992588 @default.
• W4319301683 cites W2897966671 @default.
• W4319301683 cites W2983542433 @default.
• W4319301683 cites W3022519862 @default.
• W4319301683 cites W3094602125 @default.
• W4319301683 cites W3127475641 @default.
• W4319301683 cites W3128646645 @default.
• W4319301683 cites W3128956987 @default.
• W4319301683 cites W4226470096 @default.
• W4319301683 cites W4281630496 @default.
• W4319301683 cites W4282915426 @default.
• W4319301683 doi "https://doi.org/10.1016/j.esmoop.2023.100783" @default.
• W4319301683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36753993" @default.
• W4319301683 hasPublicationYear "2023" @default.
• W4319301683 type Work @default.
• W4319301683 citedByCount "1" @default.
• W4319301683 countsByYear W43193016832023 @default.
• W4319301683 crossrefType "journal-article" @default.
• W4319301683 hasAuthorship W4319301683A5004228804 @default.
• W4319301683 hasAuthorship W4319301683A5005036299 @default.
• W4319301683 hasAuthorship W4319301683A5018623031 @default.
• W4319301683 hasAuthorship W4319301683A5024115698 @default.
• W4319301683 hasAuthorship W4319301683A5024485263 @default.
• W4319301683 hasAuthorship W4319301683A5035002011 @default.
• W4319301683 hasAuthorship W4319301683A5048534007 @default.
• W4319301683 hasAuthorship W4319301683A5052362769 @default.
• W4319301683 hasAuthorship W4319301683A5055058026 @default.
• W4319301683 hasAuthorship W4319301683A5079645039 @default.
• W4319301683 hasAuthorship W4319301683A5084197662 @default.
• W4319301683 hasAuthorship W4319301683A5087125537 @default.
• W4319301683 hasAuthorship W4319301683A5090751499 @default.
• W4319301683 hasBestOaLocation W43193016831 @default.
• W4319301683 hasConcept C121608353 @default.
• W4319301683 hasConcept C126322002 @default.
• W4319301683 hasConcept C141071460 @default.
• W4319301683 hasConcept C167135981 @default.
• W4319301683 hasConcept C185926286 @default.
• W4319301683 hasConcept C2778019345 @default.
• W4319301683 hasConcept C2778695046 @default.
• W4319301683 hasConcept C2781413609 @default.
• W4319301683 hasConcept C44249647 @default.
• W4319301683 hasConcept C530470458 @default.
• W4319301683 hasConcept C71924100 @default.
• W4319301683 hasConcept C72563966 @default.
• W4319301683 hasConcept C90924648 @default.
• W4319301683 hasConceptScore W4319301683C121608353 @default.
• W4319301683 hasConceptScore W4319301683C126322002 @default.
• W4319301683 hasConceptScore W4319301683C141071460 @default.
• W4319301683 hasConceptScore W4319301683C167135981 @default.
• W4319301683 hasConceptScore W4319301683C185926286 @default.
• W4319301683 hasConceptScore W4319301683C2778019345 @default.
• W4319301683 hasConceptScore W4319301683C2778695046 @default.
• W4319301683 hasConceptScore W4319301683C2781413609 @default.
• W4319301683 hasConceptScore W4319301683C44249647 @default.
• W4319301683 hasConceptScore W4319301683C530470458 @default.
• W4319301683 hasConceptScore W4319301683C71924100 @default.
• W4319301683 hasConceptScore W4319301683C72563966 @default.
• W4319301683 hasConceptScore W4319301683C90924648 @default.
• W4319301683 hasIssue "1" @default.
• W4319301683 hasLocation W43193016831 @default.
• W4319301683 hasLocation W43193016832 @default.
• W4319301683 hasLocation W43193016833 @default.
• W4319301683 hasOpenAccess W4319301683 @default.
• W4319301683 hasPrimaryLocation W43193016831 @default.
• W4319301683 hasRelatedWork W2074040330 @default.
• W4319301683 hasRelatedWork W2083693141 @default.
• W4319301683 hasRelatedWork W2099019067 @default.
• W4319301683 hasRelatedWork W2129038570 @default.
• W4319301683 hasRelatedWork W2183125843 @default.
• W4319301683 hasRelatedWork W2899063125 @default.
• W4319301683 hasRelatedWork W2924761199 @default.
• W4319301683 hasRelatedWork W2948428432 @default.
• W4319301683 hasRelatedWork W4252935741 @default.
• W4319301683 hasRelatedWork W2103707617 @default.
• W4319301683 hasVolume "8" @default.
• W4319301683 isParatext "false" @default.
• W4319301683 isRetracted "false" @default.

• next